Caffeine shows no lasting benefit for preemies with apnea

01/17/2012 | PhysiciansBriefing.com

A five-year study in the Journal of the American Medical Association found that neonatal caffeine treatment for apnea of prematurity did not improve survival without disability. The caffeine group and the placebo group did not differ in terms of mortality rate, behavior problems, motor impairment, poor general health, blindness or deafness, researchers reported.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC